Insider plans 100,000-share BBIO (NASDAQ: BBIO) sale under Rule 144
Rhea-AI Filing Summary
The Form 144 notice for BBIO discloses a planned sale of 100000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 7427000.00. These shares are part of a class with 192708813 shares outstanding and are expected to be sold on or about 01/08/2026 on the NASDAQ.
The securities to be sold were acquired on 03/26/2016 via conversion of management incentive units from the issuer, with no gift indicated. The notice also lists multiple Rule 10b5-1 sales of common stock during the prior three months for accounts associated with NEIL KUMAR and related trusts, each disclosing the date, number of shares sold, and gross proceeds.
Positive
- None.
Negative
- None.
FAQ
What does the BBIO Form 144 filing disclose?
The Form 144 notice discloses a planned sale of 100000 BBIO common shares with an aggregate market value of 7427000.00, to be sold on the NASDAQ.
What prior Rule 10b5-1 sales are reported in the BBIO Form 144?
The notice lists multiple Rule 10b5-1 sales of BBIO common stock in October, November, and December 2025 for NEIL KUMAR and related revocable and irrevocable trusts, each with specific share amounts and gross proceeds.
What does the Form 144 say about the seller 19s knowledge of BBIO information?
The signer represents that the person for whose account the securities are to be sold does not know any material adverse information about BBIO 19s current or prospective operations that has not been publicly disclosed.